Guidance for Industry; Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA
NonrulemakingOtherFDA-2013-D-1464-0002
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Dec 4, 2013
- Agency
- Food and Drug Administration (FDA)